Web-based program to help head and neck cancer patients with swallowing exercises
Official title: Mobile Delivery of a Coping and Adherence Program for Head and Neck Cancer Patients Being Treated in Community Care Settings
Run by M.D. Anderson Cancer Center · NCT04003051 · Data updated 2026-11-12
This study tests whether a web-based program can help head and neck cancer patients stick to their swallowing exercises during radiation therapy to improve their recovery.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Drugs / interventions | radiation |
| Locations | 2 sites (Fort Worth, Texas and 1 other locations) |
| Status | Recruiting |
| Started | March 18, 2019 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | October 6, 2026 |
| Trial ID | NCT04003051 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients receiving radiation treatment for throat cancer who can communicate in English or Spanish.
✕Probably not a fit
Patients not undergoing radiation therapy or those who cannot engage with the web-based platform may not benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This phase II trial evaluates the effectiveness of a web-based program called Project Prepare in assisting patients with head and neck cancer to adhere to swallowing and trismus exercises during radiation therapy. The program provides video demonstrations, patient stories, and practical tips to enhance recovery and manage side effects. Participants will engage with the platform over a 10-week period, with follow-up assessments at six months to measure improvements in swallowing function and adherence to exercises. The initiative aims to support underserved populations lacking access to specialized care.
Why it matters
Potential benefit: If successful, this program could significantly improve swallowing function and quality of life for patients undergoing treatment for head and neck cancer.
How similar studies have gone: Other studies have shown promise in using digital platforms for patient education and adherence, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Receiving radiation treatment with curative intent for throat cancer * Can read and speak English or Spanish well enough to answer our questionnaires and understand our website content.
Where it's running
-
Texas Health Care-Otolaryngology and Plastic Surgery Associates
Fort Worth, Texas, United States Recruiting -
M D Anderson Cancer Center
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Eileen H Shinn — M.D. Anderson Cancer Center
- Study coordinator: Eileen H Shinn
- Email: eshinn@mdanderson.org
- Phone: 713-745-0870
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Pembrolizumab with Chemotherapy for Head and Neck Cancer
This study is testing if combining a blood test that checks tumor DNA with chemotherapy and immunotherapy can help people with head and neck cancer get better results than using immunotherapy alone.
-
Lowering radiation doses in chemotherapy for HPV-positive throat cancer
This study is testing if giving lower doses of radiation along with regular chemotherapy can help people with HPV-positive throat cancer feel better and have fewer side effects after treatment.
-
Preventing heart problems in overweight/obese young sarcoma survivors with tirzepatide
This feasibility study tests whether tirzepatide can be safely given to overweight or obese young adults (18–39) who have completed doxorubicin for soft tissue or bone sarcoma to see if it’s feasible to use in the first year after therapy.
-
Predicting lymphedema risk in inflammatory breast cancer patients using preoperative body impedance analysis
This study tests whether a preoperative bioimpedance test can help identify IBC patients who are at risk for developing lymphedema.
-
Precision genomic testing to guide first-line LBCL treatment readiness
Doctors will see if a tumor genomic test can help tailor first-line treatment for adults with LBCL by the start of the second cycle of standard therapy.
-
Using Apple Vision Pro in image-guided procedures
This study tests whether the Apple Vision Pro can be used during CT-guided biopsy procedures to help with imaging and guidance.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.